What are they & what do they protect? How to apply for & get a granted patent...

723 views
664 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
723
On SlideShare
0
From Embeds
0
Number of Embeds
234
Actions
Shares
0
Downloads
11
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

What are they & what do they protect? How to apply for & get a granted patent...

  1. 1. Patents in Biotechnology: What, how & why? Dr Anton Hutter Chartered & European Patent Attorney January 2012
  2. 2. Patents: What, how & why?• What are they & what do they protect?• How to apply for & get a granted patent  Patentability requirements  Inventorship & ownership issues  How to get a granted patent• Why file a patent application?  Uses of patents  Investing in IP
  3. 3. Patents: What?
  4. 4. Patents• Protect technical inventions• A patent is an exclusive right allowing the owner to preventthird parties from doing certain things in respect of the claimedinvention:- - making- using- selling (offering to sell)- importing- keeping• Patent lasts for 20 years from filing date• Territorial nature of patents• Post-grant infringement and validity usually judged in nationalcourts
  5. 5. Patents as a monopoly• The monopoly or scope of protection is defined by the claims:  Products/articles/compositions  Processes/methods/uses• Careful claim drafting required to maximise scope of protection
  6. 6. What is patentable in bioscience?• Chemical and biological compounds per se• Biological materials (nucleotides, constructs, peptides, proteins, antibodies etc.)• Primary, secondary & tertiary structures of macromolecules• Processes for making them• Processes for using them• Substances useful in these processes, e.g. enzymes• Cell lines, micro-organisms, transgenic organisms and plants
  7. 7. What is patentable in bioscience?• Analytical/diagnostic methods• Medical uses• Drug delivery• Dosage regimens• Exclusions where contrary to „morality‟ : no protection for processes for cloning human beings, using human embryos for commercial purposes etc.
  8. 8. Patents: How?
  9. 9. PatentabilityRequirements
  10. 10. 1) Novelty• In Europe, there is an absolute novelty requirement• At date of filing, invention must not have been “made available to thepublic”:- in any way - in any language - at any time - anywhere - by anyoneExamples:-- Academic paper- Publication of an abstract on internet- Public presentation or lecture- Poster at a conference- Open discussions at a conference- PhD Thesis- Sale of a product- Non-confidential use of a product
  11. 11. Confidentiality• Invention must be confidential before application filed• Be careful what you disclose & what you keep secret• Difficult in academia due to collaborations with other institutions• Take care when trying to attract funding, writing grant proposals & promoting your work• Use a confidentiality agreement if disclosing to 3rd parties• Err on the side of caution and disclose nothing until a patent application has been filed
  12. 12. 2) Inventive Step• Invention must not be obvious over the „prior art‟ and common generalknowledge• „Prior art‟ is everything that was in the public domain before the patentapplication was filed• Inventive step is arguable:-- Unexpected or surprising result?- Use of non-routine techniques?- Not obvious to try?
  13. 13. Other patentability requirements3) Industrial Applicability• Invention must be capable of being applied in industry/agriculture• Mention at least one use in the patent application• Needed at filing date!
  14. 14. Other patentability requirements4) Sufficiency• The patent specification must be sufficiently detailed so that a personskilled in the art can repeat the invention without undue burden• Include full details of all non-routine techniques used• Needed at filing date!
  15. 15. Other patentability requirements5) Support• Include example(s) to prove the claimed invention actually works• In vitro & in vivo data• Needed at filing date!
  16. 16. Inventorship &ownership issues
  17. 17. Inventorship• Important to sort this out at the outset• The inventor is the “actual deviser” of the invention• May be a team, consider, e.g.- Academics – professors, lecturers, post-docs, post-grads, PhDstudents, undergrads, students - Consultants - External contractors- Employees - Company directors• Multi-disciplinary teams becoming more common
  18. 18. Ownership• The owner depends on the relationship between inventor(s) and otherparties involved• Usually owned by employer („employed to invent?‟)• Contract?• In academia, the university usually owns the IP• IP may subsequently be assigned from university to spin-out
  19. 19. How to get a granted patent
  20. 20. 0 months File UK application (£1.5k-£4k) Patent +12 months Filing File international (PCT) application (£3k-£5k)Procedure +15 months International Search & Written Opinion (£200) +18 months International publication +31 months File European application +30/31 months All designations File national applications (£3.5k) (£1k-£5k each) +60 months For example:- GRANT OF EUROPEAN PATENT AustraliaComplete formalities and register NATIONALLY Brazil (£500-£5k per country) Canada China For example:- India Austria Japan France Russia Germany USA Italy The Netherlands UK
  21. 21. NoIs invention new? Yes or maybe NoIs it inventive? When to patent Yes or maybe NoWould a patent be valuable? Yes or maybe No Do not file aBetter than secrecy? patent Yes or maybe application NoReasonable product life? Yes or maybe NoAre the costs justifiable? YesFile patent application
  22. 22. Patents: Why?
  23. 23. Uses of Patents
  24. 24. Patents are Commercial Tools• When building a patent portfolio, be clear about your commercial aims: - Attracting funding/investment? - Spin-out or equivalent? - Create an income stream (licensing royalties)? - As a bargaining chip in negotiations? - Deterrent effect against competitors? - Create barrier to others to enter market - Seeking a collaboration?
  25. 25. When to file?• A serious commercial opportunity is likely to require filing a patent application, even if ultimately obtaining patent protection may be challenging File patent application Do not file patent application• However, if the commercial opportunity is small, a patent application may not be justified, even if the invention is eminently patentable
  26. 26. Investing in IP
  27. 27. Due diligence • Much more than simply listing a company‟s IP portfolio • An assessment of:- (i) the strength of a company‟s IP; (ii) the strength of your competitor‟s rights • Crucial to getting funding
  28. 28. What are investors looking for? 1. Check entitlement 2. Check the inventors are correctly named 3. Assess patentability with respect to the prior art 4. Assess validity with respect to sufficiency & support
  29. 29. What are investors looking for? 5. Check if company has strong patent portfolio offering good protection 6. Check the numbers of patent families offering different breadths of protection 7. Check geographical coverage of protection 8. Check remaining term of patent protection 9. Check the company has freedom-to-operate
  30. 30. Freedom-to-operate• Look for any dominating patent rights• You may require a licence to even work in your area• Consider cross-licensing• If you have to pay royalties, this may make your commercial venture economically unviable• Without clearance for the market you wish to enter, there is always a significant risk that you will be barred, or at least have to pay a royalty stack to proceed with your business
  31. 31. Summary• A patent is an exclusive right allowing you to prevent a third party from working your invention• BUT, you need freedom-to-operate to work the invention yourself• File patent applications where commercial opportunities are good, even if ultimately obtaining broad protection may be difficult• Novelty, inventive step, industrial application, sufficiency and support• Important to get inventorship & ownership issues right at outset• Due diligence will be carried out on your patent portfolio, so think ahead• Be clear about your commercial aims
  32. 32. Thank you for your attention!Anton Hutter BSc MSc PhD CPA EPAChartered & European Patent AttorneyVenner Shipley LLP200 AldersgateLondonEC1A 7HDTel: 020 7600 4212Fax: 020 7600 4188E: ahutter@vennershipley.co.ukW: www.vennershipley.co.uk

×